The proportion of insured girls and young women completing the human papillomavirus (HPV) vaccine among those who initiated the series has dropped significantly – as much as 63 percent – since the vaccine was approved in 2006, according to new research from the University of Texas Medical Branch (UTMB) in Galveston.

Overseas travel exposes you to wonderful new experiences, but it can also expose you to potentially serious health risks. Remember – your health is your responsibility – with a bit of preparation, you can prevent an illness that could ruin your holiday, or worse.

Runny nose? Sore throat? Aching body? It's cold and flu season again! But cold and flu season doesn't have to bring with it these unpleasant symptoms or cause you to spend money on medicines, take time off work or lie in bed for days (as pleasant as that might sound now, while you're well). ...

Scientists have identified a link between different strains of malaria parasites that cause severe disease.

NPS has launched a new Facebook page for Australians to sign up and become antibiotic resistance fighters at www.facebook.com/NPSmedicinewise

1 in 5 Australians expect their doctor to prescribe antibiotics for themselves and/or their child when they have a cough or cold, new research from NPS has found.

A team of scientists from the University of North Carolina at Chapel Hill and Vanderbilt University have pinpointed the region on dengue virus that is neutralised in people who overcome infection with the deadly pathogen. The results challenge the current state of dengue vaccine research, which is based on studies in mice and targets a different region of the virus.

The discovery of how a vital immune cell recognises dead and damaged body cells could modernise vaccine technology by ‘tricking’ cells into launching an immune response, leading to next-generation vaccines that are more specific, more effective and have fewer side-effects.

Insights into how the first vaccine ever reported to modestly prevent HIV infection in people might have worked were published online in the New England Journal of Medicine. Scientists have found that among adults who received the experimental HIV vaccine during the landmark RV144 clinical trial, those who produced relatively high levels of a specific antibody after vaccination were ...

The characterisation of a rare immune cell’s involvement in antibody production and ability to ‘remember’ infectious agents could help to improve vaccination and lead to new treatments for immune disorders, say researchers from the Walter and Eliza Hall Institute.